Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Milestone Pharmaceuticals (NASDAQ: MIST) announced its participation in the upcoming Jefferies Healthcare Conference, scheduled for June 3-5, 2025, in New York. The company will be represented by Chief Financial Officer Amit Hasija and Chief Commercial Officer Lorenz Muller. Their presentation is set for June 5th at 8:10 AM EDT.
The presentation will be accessible via webcast and will remain available for replay on Milestone's website for approximately 90 days. Interested parties can find the webcast in the News & Events section at www.milestonepharma.com. Investors seeking meetings with the Milestone team during the conference should contact their Jefferies representative.
Milestone Pharmaceuticals (NASDAQ: MIST) ha annunciato la sua partecipazione al prossimo Jefferies Healthcare Conference, che si terr脿 dal 3 al 5 giugno 2025 a New York. L'azienda sar脿 rappresentata dal Chief Financial Officer Amit Hasija e dal Chief Commercial Officer Lorenz Muller. La loro presentazione 猫 programmata per il 5 giugno alle 8:10 AM EDT.
La presentazione sar脿 accessibile tramite webcast e rester脿 disponibile per la visione in replica sul sito web di Milestone per circa 90 giorni. Gli interessati potranno trovare il webcast nella sezione News & Events su www.milestonepharma.com. Gli investitori che desiderano fissare incontri con il team di Milestone durante la conferenza sono invitati a contattare il proprio rappresentante Jefferies.
Milestone Pharmaceuticals (NASDAQ: MIST) anunci贸 su participaci贸n en la pr贸xima Jefferies Healthcare Conference, programada del 3 al 5 de junio de 2025 en Nueva York. La compa帽铆a estar谩 representada por el Director Financiero Amit Hasija y el Director Comercial Lorenz Muller. Su presentaci贸n est谩 prevista para el 5 de junio a las 8:10 AM EDT.
La presentaci贸n estar谩 disponible v铆a webcast y podr谩 verse en repetici贸n en el sitio web de Milestone durante aproximadamente 90 d铆as. Los interesados pueden encontrar el webcast en la secci贸n de Noticias y Eventos en www.milestonepharma.com. Los inversores que deseen concertar reuniones con el equipo de Milestone durante la conferencia deben contactar a su representante de Jefferies.
Milestone Pharmaceuticals (NASDAQ: MIST)電� 2025雲� 6鞗� 3鞚茧秬韯� 5鞚缄箤歆� 雺挫殨鞐愳劀 鞐措Μ電� Jefferies Healthcare Conference鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 斓滉碃鞛毂呾瀯鞛� Amit Hasija鞕赌 斓滉碃靸侅梾毂呾瀯鞛� Lorenz Muller臧� 雽�響滊 彀胳劃頃� 鞓堨爼鞛呺媹雼�. 氚滍憸電� 6鞗� 5鞚� 鞓れ爠 8鞁� 10攵�(EDT)鞐� 歆勴枆霅╇媹雼�.
氚滍憸電� 鞗轨簮鞀ろ姼毳� 韱淀暣 鞁滌箔頃� 靾� 鞛堨溂氅�, 鞎� 90鞚缄皠 Milestone 鞗轨偓鞚错姼鞐愳劀 雼れ嫓氤搓赴搿� 鞝滉车霅╇媹雼�. 甏�鞁� 鞛堧姅 攵勲摛鞚� www.milestonepharma.com鞚� 雺挫姢 氚� 鞚措菠韸� 靹轨厴鞐愳劀 鞗轨簮鞀ろ姼毳� 頇曥澑頃� 靾� 鞛堨姷雼堧嫟. 旎嵓霟办姢 旮瓣皠 霃欖晥 Milestone 韺�瓿检潣 氙疙寘鞚� 鞗愴晿電� 韴瀽鞛愲姅 Jefferies 雼措嫻鞛愳棎瓴� 鞐半澖頃橃嫓旮� 氚旊瀺雼堧嫟.
Milestone Pharmaceuticals (NASDAQ : MIST) a annonc茅 sa participation 脿 la prochaine Jefferies Healthcare Conference, pr茅vue du 3 au 5 juin 2025 脿 New York. La soci茅t茅 sera repr茅sent茅e par le Directeur Financier Amit Hasija et le Directeur Commercial Lorenz Muller. Leur pr茅sentation est programm茅e pour le 5 juin 脿 8h10 EDT.
La pr茅sentation sera accessible en webcast et restera disponible en replay sur le site de Milestone pendant environ 90 jours. Les personnes int茅ress茅es peuvent trouver le webcast dans la section Actualit茅s & 脡v茅nements sur www.milestonepharma.com. Les investisseurs souhaitant organiser des rencontres avec l'茅quipe Milestone durant la conf茅rence doivent contacter leur repr茅sentant Jefferies.
Milestone Pharmaceuticals (NASDAQ: MIST) gab bekannt, dass es an der bevorstehenden Jefferies Healthcare Conference teilnimmt, die vom 3. bis 5. Juni 2025 in New York stattfindet. Das Unternehmen wird vertreten durch Chief Financial Officer Amit Hasija und Chief Commercial Officer Lorenz Muller. Ihre Pr盲sentation ist f眉r den 5. Juni um 8:10 Uhr EDT angesetzt.
Die Pr盲sentation wird per Webcast zug盲nglich sein und etwa 90 Tage lang auf der Website von Milestone zur Wiederholung bereitstehen. Interessierte finden den Webcast im Bereich News & Events unter www.milestonepharma.com. Investoren, die w盲hrend der Konferenz Treffen mit dem Milestone-Team w眉nschen, sollten ihren Jefferies-Ansprechpartner kontaktieren.
- None.
- None.
MONTREAL AND CHARLOTTE, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Milestone庐 Pharmaceuticals Inc.聽(Nasdaq: MIST) today announced that Amit Hasija, Chief Financial Officer, and Lorenz Muller, Chief Commercial Officer, will present at the Jefferies Healthcare Conference, to take place June 3 - 5, 2025, in New York.
A webcast of the presentation will be available on June 5th at 8:10 AM EDT. The webcast will be available to watch and there will be a replay for approximately 90-days following the presentation on the News & Events section of Milestone's website www.milestonepharma.com.
If you are interested in meeting with the Milestone team during the conference, please reach out to your Jefferies representative.
About Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a biopharmaceutical company developing and commercializing innovative cardiovascular solutions to improve the lives of people living with complex and life-altering heart conditions. The Company鈥檚 focus on understanding unmet patient needs and improving the patient experience has led us to develop new treatment approaches that provide patients with an active role in self-managing their care. Milestone's lead investigational product is etripamil, a novel calcium channel blocker nasal spray that is being studied for patients to self-administer without medical supervision to treat symptomatic episodic attacks associated with PSVT and AFib-RVR.
Contact:
Kim Fox, Vice President, Communications, [email protected]
Investor Relations
Kevin Gardner, [email protected]
FAQ
When is Milestone Pharmaceuticals (MIST) presenting at the Jefferies Healthcare Conference 2025?
Who will represent Milestone Pharmaceuticals (MIST) at the Jefferies Healthcare Conference?
How can I watch Milestone Pharmaceuticals' (MIST) presentation at the Jefferies Conference?
How can investors meet with Milestone Pharmaceuticals' (MIST) management at the Jefferies Conference?
